Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ada Taravella

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nature Reviews. Clinical Oncology|November 18, 2024
Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithmPaolo Ciracì, Vittorio Studiale, Ada Taravella, et al.
Cancer Treatment Reviews|April 7, 2026
Comprehensive genomic profiling in solid tumours: Navigating promise, challenges, and pathways to clinical integrationVittorio Studiale, Ada Taravella, Matteo Landi, et al.
Therapeutic Advances in Medical Oncology|January 8, 2025
Prognostic impact of depth of response and early tumour shrinkage in patients with <i>BRAF</i> <sup></sup> -mutated metastatic colorectal cancer treated with targeted therapyGuglielmo Vetere, Marco Maria Germani, Carlotta Antoniotti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 2, 2026
Sotorasib plus panitumumab and 5-fluorouracil in first-line treatment of patients with unresectable KRAS G12C mutated colorectal cancer unfit for a doublet/triplet chemotherapy: ENGIC 01 - PRODIGE 107 - FFCD 2306 - COLOSOTO trialAdrien Grancher, Matteo Landi, Alexej Ballhausen, et al.
Current Oncology (Toronto, Ont.)|September 27, 2024
The Role of Artificial Intelligence on Tumor Boards: Perspectives from Surgeons, Medical Oncologists and Radiation OncologistsValerio Nardone, Federica Marmorino, Marco Maria Germani, et al.
JCO Precision Oncology|November 7, 2024
KRASG12D-Mutated Metastatic Colorectal Cancer: Clinical, Molecular, Immunologic, and Prognostic Features of a New Emerging Targeted AlterationRoberto Moretto, Daniele Rossini, Sabina Murgioni, et al.
British Journal of Cancer|November 28, 2024
Early onset metastatic colorectal cancer patients as a distinctive clinical and molecular phenomenonAndrea Pretta, Pina Ziranu, Eleonora Perissinotto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2026
Circulating tumor DNA dynamics in patients with liver-limited metastatic colorectal cancer resected after first-line systemic treatmentRoberto Moretto, Vittorio Studiale, Seung Won Hyun, et al.
Clinical Colorectal Cancer|March 14, 2026
The Impact of Surgical Resection in Early Onset Colorectal Cancer Patients With Liver Limited DiseaseAndrea Pretta, Pina Ziranu, Francesca Bergamo, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nature Reviews. Clinical Oncology|November 18, 2024
Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithmPaolo Ciracì, Vittorio Studiale, Ada Taravella, et al.
Cancer Treatment Reviews|April 7, 2026
Comprehensive genomic profiling in solid tumours: Navigating promise, challenges, and pathways to clinical integrationVittorio Studiale, Ada Taravella, Matteo Landi, et al.
Therapeutic Advances in Medical Oncology|January 8, 2025
Prognostic impact of depth of response and early tumour shrinkage in patients with <i>BRAF</i> <sup></sup> -mutated metastatic colorectal cancer treated with targeted therapyGuglielmo Vetere, Marco Maria Germani, Carlotta Antoniotti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 2, 2026
Sotorasib plus panitumumab and 5-fluorouracil in first-line treatment of patients with unresectable KRAS G12C mutated colorectal cancer unfit for a doublet/triplet chemotherapy: ENGIC 01 - PRODIGE 107 - FFCD 2306 - COLOSOTO trialAdrien Grancher, Matteo Landi, Alexej Ballhausen, et al.
Current Oncology (Toronto, Ont.)|September 27, 2024
The Role of Artificial Intelligence on Tumor Boards: Perspectives from Surgeons, Medical Oncologists and Radiation OncologistsValerio Nardone, Federica Marmorino, Marco Maria Germani, et al.
JCO Precision Oncology|November 7, 2024
KRASG12D-Mutated Metastatic Colorectal Cancer: Clinical, Molecular, Immunologic, and Prognostic Features of a New Emerging Targeted AlterationRoberto Moretto, Daniele Rossini, Sabina Murgioni, et al.
British Journal of Cancer|November 28, 2024
Early onset metastatic colorectal cancer patients as a distinctive clinical and molecular phenomenonAndrea Pretta, Pina Ziranu, Eleonora Perissinotto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2026
Circulating tumor DNA dynamics in patients with liver-limited metastatic colorectal cancer resected after first-line systemic treatmentRoberto Moretto, Vittorio Studiale, Seung Won Hyun, et al.
Clinical Colorectal Cancer|March 14, 2026
The Impact of Surgical Resection in Early Onset Colorectal Cancer Patients With Liver Limited DiseaseAndrea Pretta, Pina Ziranu, Francesca Bergamo, et al.
Pageof 1